Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$51.32−0.33 (-0.64%)
Close on Nov 18, 2026Market cap $7.13BP/E –Yield –
Cytokinetics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cytokinetics's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 0M, up 7.3% from the year before. Over ten years it grew -43.9% a year on average. The highest annual figure on record is 49M in fiscal 2017.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +7.3% |
| FY2024 | Dec 31, 2024 | 0M | +16.0% |
| FY2023 | Dec 31, 2023 | 0M | +7.5% |
| FY2022 | Dec 31, 2022 | 0M | +16.8% |
| FY2021 | Dec 31, 2021 | 0M | +19.2% |
| FY2020 | Dec 31, 2020 | 0M | +12.1% |
| FY2019 | Dec 31, 2019 | 0M | +5.8% |
| FY2018 | Dec 31, 2018 | 0M | -99.9% |
| FY2017 | Dec 31, 2017 | 49M | +16.1% |
| FY2016 | Dec 31, 2016 | 43M | +9.7% |
| FY2015 | Dec 31, 2015 | 39M | +8.7% |
| FY2014 | Dec 31, 2014 | 36M | +30.9% |
| FY2013 | Dec 31, 2013 | 27M | +50.6% |
| FY2012 | Dec 31, 2012 | 18M | +53.4% |
| FY2011 | Dec 31, 2011 | 12M | +10.3% |
| FY2010 | Dec 31, 2010 | 11M | +10.7% |
| FY2009 | Dec 31, 2009 | 10M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 0M | +10.6% |
| Q1 FY2026 | Mar 31, 2026 | 0M | +4.0% |
| Q4 FY2025 | Dec 31, 2025 | 0M | +3.7% |
| Q3 FY2025 | Sep 30, 2025 | 0M | +2.0% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +9.4% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +16.3% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +19.2% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +22.5% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +14.1% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +7.1% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +4.6% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +2.5% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +11.7% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +12.0% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +12.5% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +16.7% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +19.5% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +19.4% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +18.7% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +17.6% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +20.4% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +20.1% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +19.8% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +16.4% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +3.4% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +8.1% |
| Q4 FY2019 | Dec 31, 2019 | 0M | -99.9% |
| Q3 FY2019 | Sep 30, 2019 | 0M | -99.9% |
| Q2 FY2019 | Jun 30, 2019 | 0M | -99.9% |
| Q1 FY2019 | Mar 31, 2019 | 0M | -99.9% |
| Q3 FY2018 | Sep 30, 2018 | 55M | +1.7% |
| Q2 FY2018 | Jun 30, 2018 | 54M | +12.6% |
| Q1 FY2018 | Mar 31, 2018 | 54M | +30.0% |
| Q4 FY2017 | Dec 31, 2017 | 54M | +24.1% |
| Q3 FY2017 | Sep 30, 2017 | 54M | +24.3% |
| Q2 FY2017 | Jun 30, 2017 | 48M | – |
| Q1 FY2017 | Mar 31, 2017 | 42M | – |
| Q4 FY2016 | Dec 31, 2016 | 44M | – |
| Q3 FY2016 | Sep 30, 2016 | 43M | – |
See a number that looks wrong?